These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 11251948

  • 1. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K.
    Cancer; 2001 Mar 01; 91(5):964-71. PubMed ID: 11251948
    [Abstract] [Full Text] [Related]

  • 2. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Offersen BV, Pfeiffer P, Hamilton-Dutoit S, Overgaard J.
    Cancer; 2001 Apr 15; 91(8):1500-9. PubMed ID: 11301398
    [Abstract] [Full Text] [Related]

  • 3. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G.
    Br J Cancer; 2000 Aug 15; 83(4):480-6. PubMed ID: 10945495
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E.
    Clin Cancer Res; 1997 Apr 15; 3(4):515-22. PubMed ID: 9815714
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
    Angeletti CA, Lucchi M, Fontanini G, Mussi A, Chella A, Ribechini A, Vignati S, Bevilacqua G.
    Cancer; 1996 Aug 01; 78(3):409-15. PubMed ID: 8697384
    [Abstract] [Full Text] [Related]

  • 6. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 7. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T.
    Clin Cancer Res; 2002 Jun 15; 8(6):1838-42. PubMed ID: 12060625
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I.
    Oncol Rep; 2004 Oct 15; 12(4):849-53. PubMed ID: 15375511
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC, Harris AL, Gatter KC.
    J Pathol; 1996 May 15; 179(1):80-8. PubMed ID: 8691350
    [Abstract] [Full Text] [Related]

  • 11. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
    Gupta S, Joshi K, Wig JD, Arora SK.
    Acta Oncol; 2007 May 15; 46(6):792-7. PubMed ID: 17653902
    [Abstract] [Full Text] [Related]

  • 12. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T.
    Eur J Cardiothorac Surg; 2004 Mar 15; 25(3):443-8. PubMed ID: 15019676
    [Abstract] [Full Text] [Related]

  • 13. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 15; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 14. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 15. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma LJ, Belderbos JS, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1378-87. PubMed ID: 15050313
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H, Iizasa T, Shibuya K, Iyoda A, Suzuki M, Moriya Y, Liu TL, Hiwasa T, Hiroshima K, Fujisawa T.
    Cancer; 2004 Apr 15; 100(8):1665-72. PubMed ID: 15073855
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
    Fontanini G, De Laurentiis M, Vignati S, Chinè S, Lucchi M, Silvestri V, Mussi A, De Placido S, Tortora G, Bianco AR, Gullick W, Angeletti CA, Bevilacqua G, Ciardiello F.
    Clin Cancer Res; 1998 Jan 15; 4(1):241-9. PubMed ID: 9516978
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N.
    Cancer; 2003 Aug 01; 98(3):535-41. PubMed ID: 12879471
    [Abstract] [Full Text] [Related]

  • 20. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
    Saji H, Nakamura H, Awut I, Kawasaki N, Hagiwara M, Ogata A, Hosaka M, Saijo T, Kato Y, Kato H.
    Ann Thorac Cardiovasc Surg; 2003 Oct 01; 9(5):295-300. PubMed ID: 14672525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.